Jump to start of content

ABIM will be closed from 1:00 p.m. Friday, 5/24/24 through Monday, 5/27/24 Expand/Collapse the ABIM alert.

Our offices will re-open on Tue., 5/28/24 at 8:30 a.m. ET. For your convenience, you may contact us by email at request@abim.org.

Breadcrumb trail:

ABIM Council

Expand All | Collapse All

Asher A. Tulsky, MD, Chair

Asher A. Tulsky, MDDr. Tulsky is a board certified internist. He is Associate Professor of Medicine at the Boston University School of Medicine and Associate Chief of Education in the section of General Internal Medicine. His career has focused on postgraduate medical education, and he is currently Director of Resident Development at Boston Medical Center in Massachusetts.

Previously, he was Associate Program Director at the University of Pittsburgh Internal Medicine Residency program, directed their community-based residency program, established and directed the International Scholars Program for gifted and accomplished international medical graduates pursuing academic medicine careers and was the principal consultant in a collaboration between the University of Pittsburgh and the Teine Keijinkai Hospital in Sapporo, Japan, in establishing a U.S.-modeled internal medicine residency program.

Dr. Tulsky is the chair of Internal Medicine's (ABIM) Council, he is also Chair of the ABIM Internal Medicine Specialty Board and served for eight years on the ABIM Internal Medicine Board Exam Committee. He is also an active member of the Association of Program Directors of Internal Medicine.

Dr. Tulsky earned his medical degree from the Chicago Medical School in Illinois, completed internal medicine residency training at the Michael Reese Hospital and Medical Center, also in Chicago, and fellowship in general internal medicine at the University of Rochester School of Medicine and Dentistry in New York.

As of July 2022, Dr. Tulsky reported no ongoing external relationships.

Laura Evans, MD, MSc, Chair-Elect

Laura E. Evans, MD

Dr. Evans is a Professor of Medicine at the University of Washington and the Medical Director of Critical Care at the University of Washington Medical Center in Seattle. She is board certified in Critical Care Medicine, Internal Medicine, Hospice and Palliative Medicine and Pulmonary Disease. Her interests focus on education, patient safety and quality improvement in the intensive care unit, particularly around sepsis.

She joined the Critical Care Medicine Board of the American Board of Internal Medicine in 2014. She has served as the Chair of the Internal Medicine Section of the Society of Critical Care Medicine and served on the Guidelines Oversight Committee of the American College of Chest Physicians. She currently serves as the Surviving Sepsis Campaign Guidelines co-Chair on the Council of the Society of Critical Care Medicine.

Dr. Evans earned her medical degree at the University of Michigan and completed her internal medicine residency at Columbia University. She completed pulmonary and critical care medicine fellowship training and earned a master of science degree in epidemiology at the University of Washington.

As of May 2023, Dr. Evans reported the following external relationships:

Dr. Evans serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • The Society of Critical Care Medicine, Surviving Sepsis Campaign Guidelines, co-Chair, COVID-19 Management Guidelines, co-Chair; Council, Member, without compensation.

Grant funding for salary support, research expenses and staff, paid to the University of Washington Medical Center, from the following organizations:

  • CDC Foundation, serving as a Principal Investigator for a study of severe acute respiratory infection, including COVID-19, in hospitalized patients, receiving funding for salary support, research expenses and staff.
  • The Centers for Disease Control and Prevention, serving as an investigator on a project to strengthen approaches to infection prevention and control, funding for salary support, research expenses and staff.
  • National Emerging Special Pathogens Training and Education Center, receiving funding for salary support.
  • The National Institutes of Health, serving as an investigator on a study of the impact of sepsis bundle implementation on patients presenting to the emergency department with sepsis, receiving funding for salary support.

Dr. Evans also serves as a scientific advisory committee member for Endpoint Health regarding precision medicine approaches to sepsis.

Erica N. Johnson, MD, FACP, FIDSA, Council Director

Erica N. Johnson, MD

Dr. Johnson is Assistant Professor of Medicine in the Division of Infectious Diseases at Johns Hopkins University School of Medicine and the Program Director for the Internal Medicine Residency at Johns Hopkins Bayview Medical Center in Baltimore, Maryland. She is board certified in Internal Medicine and Infectious Disease and is a fellow of the American College of Physicians and the Infectious Disease Society of America.

In 2014, Dr. Johnson completed an 11-year career in the U.S. Army Medical Corps, where she served as the Associate Program Director for the Internal Medicine Residency and Infectious Disease Fellowship Programs in the San Antonio Uniformed Services Health Education Consortium. She also served as a clinical investigator with the Infectious Disease Clinical Research Program.

Dr. Johnson is the Chair of the American Board of Internal Medicine (ABIM) Infectious Disease Board and ABIM Council member. She is active in the Academic Alliance of Internal Medicine and the Infectious Diseases Society of America. She also co-directs the annual Johns Hopkins Infectious Disease Update Course for Primary Care and Hospital Medicine. Dr. Johnson has been recognized with numerous research, teaching and community service awards, including the San Antonio Uniformed Services Health Education Consortium Lieutenant General PK Carlton Outstanding Faculty Award; the Women of Color Science, Technology, Engineering and Math Conference Technology Rising Star Award; and the C. Lockard Conley Award for Teaching Excellence from the Maryland Chapter of the American College of Physicians.

Dr. Johnson received her bachelor’s degree in classics from the University of Virginia in Charlottesville, Virginia, and her medical degree from the University of Maryland in Baltimore, Maryland. She completed a residency in internal medicine at Walter Reed Army Medical Center in Washington, DC, and a fellowship in infectious disease at Brooke Army Medical Center in San Antonio, Texas.

As of May 2023, Dr. Johnson reported the following external relationships:

Dr. Johnson serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • The Accreditation Council for Graduate Medical Education, Review Committee for Internal Medicine, Member, without compensation
  • The Infectious Diseases Society of America, Education Committee, Member, without compensation

Ashok Balasubramanyam, MD

Ashok Balasubramanyam, MD

Dr. Balasubramanyam, a board-certified internist and endocrinologist, is Professor of Medicine, Rutherford Professor of Diabetes Research and Vice President for Academic Integration at Baylor College of Medicine. His academic career has involved basic and translational research, education (as past director of the Endocrine Fellowship Program and currently of Baylor’s Clinical Scientist Training Program) and clinical service.

Dr. Balasubramanyam is a member of the ABIM Council and the Chair of the Endocrinology, Diabetes, and Metabolism Board of the American Board of Internal Medicine. He is a past president of the Association of Program Directors in Endocrinology and Metabolism. 

Dr. Balasubramanyam earned his undergraduate degree at Yale University and his medical degree at St. John’s Medical College, Bangalore, India. He completed internal medicine residency training and was Chief Resident at Baylor College of Medicine, and completed clinical and research fellowship training in endocrinology at the Massachusetts General Hospital, Boston.

As of October 2022, Dr. Balasubramanyam reported the following external relationships:

Work as an author or editor for the following company, with compensation as listed below:

  • UpToDate®,  receiving compensation for authorship on ketosis-prone diabetes.

Dr. Balasubramanyam serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • Harris County Medical Society, Executive Board Member, without compensation.

Kenneth R. DeVault, MD

Kenneth R. DeVault, MDDr. DeVault is Professor and Chair of the Department of Medicine at Mayo Clinic Florida. He is a member of the Executive Operating Team of Mayo Clinic in Florida. Dr. DeVault is board certified in Internal Medicine and Gastroenterology.

Prior to becoming Chair of Medicine, Dr. DeVault was Chair of the Division of Gastroenterology and Hepatology at the Mayo Clinic Florida from 2005-2010. He served as a member of the American Board of Internal Medicine’s Gastroenterology Board and became chair in 2023. Dr. DeVault is a Fellow of and past president of the American College of Gastroenterology. He is also a member of the American Gastroenterological Association and the American Society for Gastrointestinal Endoscopy, and a fellow of the American College of Physicians.

Dr. DeVault conducts research on disorders affecting all aspects of the esophagus and has written more than 250 book chapters, abstracts, editorials and original articles on subjects ranging from treatment of GERD, dysphagia, esophagitis and Barrett's esophagus to laparoscopic anti-reflux surgery and managed care issues in the treatment of GERD. He also has interest in gastrointestinal health in the third world, improving professionalism in both trainees and practicing physicians and in the development of a diverse and effective health care work force.

He received his undergraduate degree from the University of Tennessee and his medical degree from the Bowman Gray School of Medicine at Wake Forest University. He completed his internship and residency in internal medicine at Vanderbilt University and completed a combined clinical and research fellowship at Jefferson Medical College.

As of May 2023, Dr. DeVault reported no ongoing external relationships.

Laura Dingfield, MD

Dr. Dingfield is Assistant Professor of Clinical Medicine at the Perelman School of Medicine at the University of Pennsylvania, Director of Palliative Care Education for the University of Pennsylvania Health System, and Program Director of the Hospice and Palliative Medicine Fellowship at the University of Pennsylvania in Philadelphia. She is board certified in Internal Medicine, Pediatrics, and Hospice and Palliative Medicine. Her academic focus is on medical education, including curricular innovation and assessment in competency-based education programs.

Dr. Dingfield serves on the American Academy of Hospice and Palliative Medicine (AAHPM) Fellowship Training Committee, the AAHPM Assessment Task Force, and has previously served on Test Materials Development Committees for the National Board of Medical Examiners.

Dr. Dingfield graduated from the University of Michigan Medical School in Ann Arbor. She completed her internal medicine-pediatrics residency at the Hospital of the University of Pennsylvania-Children’s Hospital of Philadelphia, and her hospice and palliative medicine fellowship at the University of Pennsylvania Health System, also in Philadelphia. She holds a master’s degree in education from the University of Pennsylvania Graduate School of Education.

As of July 2022, Dr. Dingfield reported the following external relationships:

Dr. Dingfield serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • The American Academy of Hospice & Palliative Medicine, Committee Member, without compensation.

Grant funding for staff and expenses, paid to the Perelman School at the University of Pennsylvania, from the following organizations:

  • The Allen H. and Selma W. Berkman Charitable Trust
  • Josiah Macy Jr. Foundation

Morie Gertz, MD, MACP

Dr. Gertz is the Roland Seidler Jr. Professor of the Art of Medicine and Chair of the Department of Medicine at the Mayo Clinic in Rochester, Minnesota. He is board certified in Internal Medicine, Hematology and Medical Oncology, and is an active participant in the Maintenance of Certification program. Previously, Dr. Gertz served as Treasurer for the International Myeloma Society and President of Mayo Staff Officers and Councilors. He also formerly chaired the Mayo Personnel Committee. He currently serves on the American Society of Hematology Training Program Committee and the American Board of Internal Medicine Hematology Board, to which he was appointed chair in 2023.

Dr. Gertz has been recognized as a Mayo Distinguished Clinician and in 2014 received the Jan Waldenström Medal for Medical and Scientific Achievements in Waldenström's Macroglobulinemia. He is recognized for contributions in amyloidosis and Waldenström's macroglobulinemia. He has authored more than 500 peer-reviewed publications in the field and is a frequently invited speaker across the country.

Dr. Gertz is a Master of the American College of Physicians. His undergraduate degree was awarded with highest distinction from Northwestern University, where he graduated Phi Beta Kappa. Dr. Gertz received his medical degree cum laude from Loyola University Chicago’s Stritch School of Medicine in Maywood, Illinois, where he was elected to Alpha Omega Alpha, the medical honor society. He completed a three-year medical residency at Rush-Presbyterian-St. Luke’s Medical Center in Chicago and where he was twice voted Resident of the Year.

As of July 2022, Dr. Gertz reported the following external relationships:

Funding for clinical trial expenses and staff, from the following companies:

  • Alnylam, for a trial of imRNA for familial amyloidosis, providing funding for staff, paid to the Mayo Clinic
  • Ionis, for a trial of iRNA for familial amyloidosis, providing funding for staff and expenses
  • Pfizer, for a trial of tafamidis for cardiac amyloidosis, providing funding for staff, paid to the Mayo Clinic
  • Protega Pharma, for a trial of serum TTR, paid to the Mayo Clinic

Attendance at investigators’ meetings, with compensation as listed from the following company:

  • Akcea Therapeutics, to discuss a strategic planning model, receiving reimbursement for travel expenses and honoraria

Service on data and safety monitoring boards for the following companies, with honoraria:

  • AbbVie
  • Celgene, for a Phase III trial of venetoclax

Service on a research-related expert panel or advisory board for the following company, with compensation as listed:

  • Celgene, to advise on medical content of lectures sponsored by the company, receiving reimbursement for travel expenses and honoraria

Research-related consulting for the following company, with honoraria:

  • Sanofi

Industry-supported continuing medical education supported by the following, with compensation as listed:

  • Alnylam, receiving honoraria

Teaching in industry-sponsored satellite symposia with funding from the following companies, with compensation as listed:

  • Johnson & Johnson, receiving honoraria
  • Research to Practice, receiving honoraria

Dr. Gertz serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • The American Society of Hematology, Training Committee, receiving reimbursement for travel expenses
  • The Amyloidosis Support Network, receiving reimbursement for travel and other expenses associated with providing lectures to patients
  • The International Waldenstrom’s Macroglobulinemia Foundation, receiving reimbursement for travel and other expenses associated with providing lectures to patients

 

Salahuddin Kazi, MD

Dr. Kazi, a board certified internist and rheumatologist, is the Vice Chair of Education for the Department of Internal Medicine and a Professor of Medicine in the Division of Rheumatic Diseases at University of Texas (UT) Southwestern Medical Center in Dallas. He is also the Director of the Internal Medicine Residency Training Program at UT Southwestern. Dr. Kazi is the Chair of the American Board of Internal Medicine Rheumatology Board. Dr. Kazi previously served as the Chair of the Registries and Health Information Technology Committee of the American College of Rheumatology overseeing the development of the RISE registry. Dr. Kazi continues to lead efforts in rheumatology to promote improvement in the delivery of healthcare through the principles of co-production.

Dr. Kazi earned his medical degree from Dow Medical College in Karachi, Pakistan, and completed his residency, chief residency, and fellowship in rheumatology at the University of Texas Health Science Center in Houston.

As of July 2022, Dr. Kazi reported no external relationships

Tommye Lambert, DMin, MDiv

Tommye Lambert, MDivDr. Lambert is the mother and life-long caregiver to her daughter, Amy Crews, who passed away at age twenty-eight from complications associated with cystic fibrosis and lung transplantation. During that time, she interacted with pulmonary care clinicians and health care professionals at five centers, including critical care and transplant teams. She is a leader in the patient and caregiver community providing training and facilitating discussions focused on assisting in improved patient care through patient-doctor communication and collaboration. She serves as a public/patient member on the American Board of Internal Medicine (ABIM) Council.

Dr. Lambert is active with the National Cystic Fibrosis Foundation (CFF). She serves on the Palliative Care Guidelines Committee, as a CFF MiniCon panelist, as a parent/patient advocate, as a legislative forum volunteer, and has been active in annual fundraising activities for CFF for more than 30 years. Dr. Lambert advocates for organ donation by speaking and fundraising through Legacy of Hope, formerly Alabama Organ Center.

Professionally, Dr. Lambert is a member of the clergy at Hunter Street Baptist Church in Birmingham AL where she serves as the Manager of the Home Front Resource Center. She also serves on the Advisory Board of Shepherd’s Fold, a re-entry program for those transitioning from incarceration and on the Alumni Advisory Board for Beeson Divinity School at Samford University in Birmingham, Alabama.

Dr. Lambert earned a doctorate in ministry and a master's degree in divinity from Beeson Divinity School, Samford University in Birmingham. She earned a bachelor's degree in medical technology from the University of Southern Mississippi in Hattiesburg, Mississippi.

As of June 2023, Ms. Lambert reported the following ongoing external relationships:

Ms. Lambert serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • Alabama Health Needs Advocacy Group, Cystic Fibrosis and Other Lung Diseases representative, without compensation
  • The Cystic Fibrosis Foundation, Palliative Care Guidelines Committee, Alabama Chapter Member, without compensation

Julianne Morath, RN

Ms. Morath is an international consultant in patient safety and healthcare quality leadership. Her work focuses on creating cultures of safety and designing reliability into clinical practice and the structures and mechanisms that support patient care. She is noted for her work in promoting workforce engagement and interdisciplinary alignment, and patient, family, and community advocacy.

Ms. Morath has served in executive positions and academic appointments at the University of Cincinnati, Brown University and Vanderbilt University Academic Medical Centers. Her executive experience also includes Children's Hospitals and Clinics of Minnesota; Allina Health System, and founding the Hospital Quality Institute, supporting more than 400 California hospitals and health systems. She is a founding and current member of the Lucian Leape Institute of the National Patient Safety Foundation and serves as faculty at the Institute for Healthcare Improvement.

Ms. Morath served as a member of the Board of Commissioners of The Joint Commission. She holds current appointments on multiple governing and advisory boards, including the Collaborative for Accountability and Improvement, Center for Scholarship Quality and Patient Safety, University of Washington School of Medicine, MedStar Quality and Patient Safety Institute Advisory Board, and Board of Trust, Virginia Mason Medical Center and Health Care System.

She was the inaugural recipient of the John Eisenberg Award for Individual Lifetime Achievement in Patient Safety from the National Quality Forum and The Joint Commission. In 2018, she received the Beau Biden Humanitarian Award from the Patient Safety Movement Foundation. Of more than 50 published works, she has authored two books: Do No Harm and The Quality Advantage and contributed to six major reports from the Lucian Leape Institute on topics of transforming healthcare.

Ms. Morath earned her master's degree in nursing from the University of California, San Francisco and her undergraduate degree from the University of Michigan, Ann Arbor.

As of May 2023, Ms. Morath reported the following external relationships:

Ms. Morath serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • Lucian Leape Institute, founding and current member, receiving reimbursement for travel expenses.

Ms. Morath also reported work as a consulting member of a workgroup in patient safety in dentistry at the American Dental Association.

Suresh Nair, MD

Dr. Nair is the Physician-in-Chief of the Lehigh Valley Cancer Institute (LVCI) in Allentown, Pennsylvania, and leads the health network’s academic programs. Dr. Nair is the Medical Director of the LVCI membership in the Memorial Sloan Kettering Cancer Center Alliance and has practiced oncology in the community setting for 27 years. He is the initial holder of The Auxiliary of Lehigh Valley Hospital Endowed Chair in Cancer.

With clinical expertise in melanoma, kidney cancer, and immunotherapy, Dr. Nair’s focus is to provide the highest-quality cancer care, including standard and research treatments. He leads a variety of clinical trials at Lehigh Valley Health Network (LVHN) to provide leading-edge options to patients. He leads the high dose interleukin-2 program at LVHN for advanced melanoma and kidney cancer. Dr. Nair started the hematology/oncology fellowship at LVHN and served as the initial Program Director.

Dr. Nair has been a site Principal Investigator in the National Cancer Institute (NCI) Cooperative Group Program for over 25 years and was the first Chair of the NCI Early Phase Central Institutional Review Board. He has been a site Principal Investigator of over 40 T-cell checkpoint inhibitor trials at the LVCI.

Dr. Nair received his medical degree from Jefferson Medical College in Philadelphia, Pennsylvania. He completed his residency at Geisinger Medical Center in Danville, Pennsylvania, and his fellowship at the University of Pittsburgh in Pennsylvania.

As of May 2023, Dr. Nair reported the following external relationships:

Funding for clinical trial support accrual, paid to Lehigh Valley Health Network, from the following companies:

  • Bristol-Myers Squibb, for Phase II and Phase III immuno-oncology clinical trials.
  • DNAtrix, for a Phase II clinical trial for treatment of glioblastoma.
  • Immunocore, for immuno-oncology clinical trials
  • Merck, for a Phase III clinical trial for treatment of metastatic renal carcinoma.
  • DNAtrix, for a Phase II clinical trial for treatment of glioblastoma.
  • Nektar, for immuno-oncology clinical trials.
  • Strata, for genomics testing and clinical trials.

Michael E. Nelson, MD

Michael E. Nelson, MD

Dr. Nelson is a practicing physician in Shawnee Mission, Kansas. He is a member of the staff of AdventHealth Shawnee Mission Medical Center, where he has previously served as the Chairman of the Department of Internal Medicine. His certifications from the American Board of Internal Medicine (ABIM) include Internal Medicine, Pulmonary Disease, Critical Care Medicine and Sleep Medicine. He also holds a certification in Sleep Medicine from the American Board of Sleep Medicine.

Currently, Dr. Nelson serves as a member of the ABIM Council. He is also a member of the Board of Regents of the American College of Chest Physicians (CHEST) and the Joint Clinical Practice Committee of the American Thoracic Society (ATS)/CHEST. He has been an active participant in the educational programs of the American College of Physicians and the American College of Chest Physicians (ACCP). Dr. Nelson serves as the Alternate Advisor to the American Medical Association's Current Procedural Terminology Committee for the CHEST and the ATS.

Dr. Nelson earned his medical degree at the University of Kansas School of Medicine in Kansas City. He completed his residency and chief residency in internal medicine, as well as a fellowship in pulmonary and critical care medicine, at the Department of Medicine at the University of Kansas.

As of June 2023, Dr. Nelson reported the following external relationships:

Dr. Nelson serves in significant roles with the following healthcare-related organizations, receiving reimbursement or compensation as listed:

  • The American College of Chest Physicians, Board of Regents, Member, without compensation; Health Policy and Advocacy Committee, Chair, without compensation; alternate CPT advisor, without compensation
  • The American Thoracic Society, ATS/CHEST Clinical Practice Committee, Member, without compensation; alternate CPT advisor, without compensation
  • Medical Education Resources, lectures on pulmonary disease and sleep medicine, receiving reimbursement for travel expenses

John J. Oppenheimer, MD

Dr. Oppenheimer is the Director of Clinical Research at Pulmonary and Allergy Associates as well as Clinical Professor of Medicine at University of Medicine and Dentistry New Jersey-Rutgers in Newark. He is board certified in Internal Medicine and Allergy and Immunology. He trained and was on faculty at the National Jewish Center in Denver, Colorado. Dr. Oppenheimer has participated in over 100 clinical studies with over 200 publications. He serves as the Associate Editor of the Annals of Allergy Asthma and Immunology, co-Section Editor of Current Reports of Allergy and Immunology, Current Opinion of Allergy and Immunology and serves as a reviewer for several journals including the Journal of Allergy and Clinical Immunology and JAMA. He also serves as a member of the American Board of Internal Medicine Council.

He is the past Chairman of the Asthma Diagnosis and Treatment Interest Section as well as the Interest Section Coordinating Committee of the American Academy of Allergy, Asthma and Immunology. He also serves on the Joint Task Force of the Practice Parameter Committee for Allergy Immunology, the writing committee of the Cough Guidelines Committee for the American College of Chest Physicians and is a voting member of Physician Consortium for Performance Improvement and member of the measures development for atopic dermatitis. He was on the Board of Directors of the American Board of Allergy and Immunology (ABAI) 2010-2015 and is the past Chairman of the ABAI. He has focused his career on guideline development and has been actively involved in measurement development in the field of allergy and immunology.

As of May 2023, Dr. Oppenheimer reported the following external relationships:

Preclinical research, with funding for salary support, from the following company:

  • AbbVie, for evaluation of potential anaphylaxis.

Funding for clinical trial expenses and staff, paid to Pulmonary and Allergy Associates, P.A., from the following company:

  • The National Institute of Allergy and Infectious Diseases, for a study of dupilumab efficacy based upon IL14 promoter gene polymorphisms.

Attendance at investigators’ meetings, with compensation for travel expenses from the following company:

  • Novartis, regarding omalizumab.

Service on data and safety monitoring boards for the following companies, with honoraria:

  • AstraZeneca, Chair of tezepelumab adjudication committee.
  • GlaxoSmithKline, regarding mepolizumab.
  • Sanofi, regarding dupilumab.

Service on a research-related expert panel or advisory board for the following company, without compensation:

  • GlaxoSmithKline, for advising on a closed triple pivotal trial design.

Work funded by educational grants from industry, paid to Pulmonary and Allergy Associates, P.A., from the following company:

  • Sanofi, providing funding for two continuing medical education programs for severe asthma.

Work as an author or editor for the following companies, with compensation as listed:

  • The American College of Allergy, Asthma & Immunology, Annals of Allergy, Asthma & Immunology, receiving compensation as associate editor.
  • UpToDate®, receiving compensation as an editor.

Rudolph A. Rodriguez, MD

Dr. Rodriguez, a board certified internist and nephrologist, is the Director of the Hospital & Specialty Medicine Service Line at the VA Puget Sound Health Care System and a Professor and Vice Chair of the Department of Medicine at the University of Washington in Seattle. As a clinician scholar, his academic career focused on nephrology fellowship education, along with scholarly work on issues related to vulnerable populations.

Dr. Rodriguez serves as a member of the American Board of Internal Medicine Nephrology Board. He is the Chair of the Veteran Affairs Nephrology Field Advisory Committee. He served on the American Society of Nephrology Training Program Director’s Executive Committee.

Dr. Rodriguez attended Stanford University and earned his medical degree at the Charles Drew/UCLA Medical Education Program at the University of California, Los Angeles. He completed his internal medicine residency at California Pacific Medical Center, and his nephrology fellowship training at the University of California, San Francisco.

As of July 2022, Dr. Rodriguez reported the following external relationships:

Dr. Rodriguez serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • Veterans Affairs, Field Advisory Committee, Chair, without compensation.

Jorge G. Ruiz, MD, FACP

Jorge Ruiz, MD

Dr. Ruiz is Associate Professor of Clinical Medicine and former Director of the University of Miami / Jackson Health System Geriatric Medicine Fellowship in the Division of Geriatrics and Palliative Medicine at the University of Miami Miller School of Medicine in Florida. He is also the Associate Director for Clinical Affairs and Senior Investigator at the Miami VA Geriatric Research, Education, and Clinical Center (GRECC).

Dr. Ruiz has been involved in geriatrics education at the undergraduate, graduate, and continuing professional development levels. Appointed as VA GRECC Associate Director for Clinical Affairs in 2013, he serves in a leadership role in program development that includes a portfolio of innovative clinical demonstration projects related to the care of older adults with frailty and dementia. He is also the Chair of the Miami VA Healthcare System Dementia Committee, Director of the Miami VA Memory Disorders and Falls Prevention Clinics and the leader of the Veterans Successful Aging for Frail Elders program.

His research interests include the study of risks factors for frailty in veterans, the development, implementation and evaluation of care models that aim to reduce the burden of frailty in older Veterans, the use of mesenchymal stem cell therapies to treat aging frailty and Alzheimer's disease, and the development of population-based strategies to prevent dementia. Dr. Ruiz has authored several book chapters and peer-reviewed publications.

Dr. Ruiz is an international medical graduate from the Universidad Peruana Cayetano Heredia, Lima, Peru. He is a fellowship-trained geriatrician, board certified in internal medicine, and geriatric medicine.

As of August 2022, Dr. Ruiz reported no ongoing external relationships.

Andrea Russo, MD

Dr. Russo, board certified in Cardiovascular Disease and Clinical Cardiac Electrophysiology, is Professor of Medicine at Cooper Medical School of Rowan University, Academic Chief of Division of Cardiology, Director of Electrophysiology and Arrhythmia Services, and Director of the Clinical Cardiac Electrophysiology Fellowship Program at Cooper University Hospital in Camden, New Jersey. Dr. Russo serves as Chair of the American Board of Internal Medicine (ABIM) Cardiovascular Disease Board and member of the ABIM Council. She previously served on the ABIM Cardiovascular Test Writing Committee and the American Board of Medical Specialties Continuing Board Certification Vision for the Future Commission.

She is past President of the Heart Rhythm Society (HRS), current member of the American Heart Association (AHA) Atrial Fibrillation Systems of Care Advisory Committee and member of the American College of Cardiology (ACC) Cardio-Obstetrics Council. She previously served on or chaired multiple HRS, ACC, or AHA committees, subcommittees or working groups. In addition, she has served as co-Chair or member on several guideline and consensus documents, as well as Appropriate Use criteria writing groups. She also serves on editorial boards for several peer reviewed journals and is a current Associate Editor for Circulation: Arrhythmia and Electrophysiology. She has served on steering committees, events committees, and data safety monitoring committees for several clinical trials. Her areas of research interest include implantable cardioverter defibrillators, atrial fibrillation therapies, sex differences in arrhythmias, and the role of digital health in arrhythmia management.

As of November 2022, Dr. Russo reported the following external relationships:

Funding for clinical trial expenses and staff, paid to Cooper University, from the following companies:

  • Boston Scientific
  • Kaestra 
  • Medi-Lynx
  • Medtronic

Service on data and safety monitoring boards for the following company, with honoraria:

  • Biosense Webster Inc.

Service on a research-related steering committee for the following companies, without compensation:

  • Bayer
  • Medtronic

 Research-related consulting for the following companies with honoraria:

  • Abbott
  • Atricure
  • Biosense Webster Inc.
  • Medtronic
  • PaceMate

Industry-supported continuing medical education supported by the following, with compensation for travel expenses and honoraria:

  • Medtronic
  • Sanofi

Work as an author or editor for the following company, with compensation as listed:

  • UpToDate®, receiving compensation as an editor and author for chapters related to implantable cardioverter defibrillator therapy.

Dr. Russo serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • The Heart Rhythm Society, past President, receiving reimbursement for travel expenses.

Robert Stansbury, MD

Dr. Stansbury is an Associate Professor of Medicine and Director of the West Virginia University (WVU) Sleep Evaluation Center in Morgantown. He is the Sleep Medicine Fellowship Program Director at WVU. He is ABIM board-certified in Pulmonary Disease, Critical Care Medicine, and Sleep Medicine.

He is an active member of the American Thoracic Society and the American Academy of Sleep Medicine and has served in multiple leadership roles including as committee chair for these societies. He is President of the West Virginia Sleep Society and an active member of the West Virginia Rural Health Association.

His research has involved team science and collaboration across multiple institutions. His interest and investigations broadly focus on three main areas: rural health inequity, novel approaches to the diagnosis and management of sleep apnea, and the physiology of occupational lung disease. Dr. Stansbury has published multiple research and review articles in these domains and multiple books chapters focused on sleep medicine and occupational lung disease.

Dr. Stansbury earned his medical degree at WVU School of Medicine and completed his internal medicine residency at the University of Kentucky College of Medicine in Lexington, Kentucky. He completed his pulmonary and critical care fellowship at WVU and his sleep medicine fellowship at the University of Pittsburgh School of Medicine in Pennsylvania.

As of July 2022, Dr. Stansbury reported the following external relationships:

Work as an author or editor for the following company, with compensation as listed:

  • Elsevier, Book Chapter in Principles and Practice Sleep Medicine.

Dr. Stansbury serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • The American Academy of Sleep Medicine, Program Committee, without compensation.
  • The American Thoracic Society, Quality Improvement and Implementation Committee, without compensation.

Lynn T. Tanoue, MD, MBA

Lynn T. Tanoue, MDDr. Tanoue is board certified in Internal Medicine, Pulmonary Diseases, and Critical Care Medicine. She is Professor of Medicine in the Section of Pulmonary, Critical Care, and Sleep Medicine, and Vice-Chair for Clinical Affairs in the Department of Internal Medicine at Yale School of Medicine in New Haven, Connecticut. She directs the Yale Screening and Nodule Program at Smilow Cancer Hospital at Yale-New Haven, co­directs the Yale Thoracic Oncology Program, and is the principal investigator of the Yale Lung Cancer Biorepository. Her academic focus is in the field of thoracic oncology.

Dr. Tanoue is a member of the American Board of Internal Medicine's Council, and is currently chair of the American Thoracic Society Thoracic Oncology Assembly. She has served in leadership roles in the American College of Chest Physicians and the National Association for the Medical Direction of Respiratory Care. She serves on numerous committees at her home institutions, including as a member of the governing Board of Yale Medicine, and as immediate pastPresident of the medical staff of Yale New Haven Hospital. Dr. Tanoue is currently President of the Board of Directors of the Yale Medical Symphony Orchestra.

Dr. Tanoue received her bachelor’s degree from Harvard University and medical degree from Yale School of Medicine. She did her internal medicine residency, chief residency and fellowship in pulmonary/critical care medicine at Yale-New Haven Hospital. Dr. Tanoue received her master's degree in business administration from Yale School of Management.

As of July 2022, Dr. Tanoue reported the following external relationships:

Work as an author or editor for the following companies, with compensation as listed:

  • Elsevier, receiving compensation as an Editor of The Year Book of Pulmonary Disease.
  • UpToDate,®  

Dr. Tanoue serves in significant roles with the following healthcare-related organizations, receiving reimbursement or compensation as listed:

  • American College of Chest Physicians, faculty, receiving honoraria and reimbursement for travel expenses.
  • American Thoracic Society, Chair, Thoracic Oncology Assembly, receiving reimbursement for travel expenses.